Conducted in the United States, the double-blind, placebo-controlled Osteoarthritis Pain Treatment IncorpOrating NEM (OPTION) Study, tested the effects of a 500 mg daily dose of NEM on pain and stiffness associated with osteoarthritis of the knee.